NCT06293326View on ClinicalTrials.gov

A First-in-Human Study to Learn How Well a Bi-Layer Calcium Carbonate Antacid Tablet Works Compared to a Standard, Non-Layered Calcium Carbonate Tablet in Healthy Male Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

March 6, 2024

Primary Completion Date

May 15, 2024

Study Completion Date

May 15, 2024

Conditions
HeartburnIndigestionStomach Acid Related SymptomsNocturnal Stomach Acid Related SymptomsHealthy Volunteers
Interventions
DRUG

bi-layer calcium carbonate tablet (BAY1180654)

Singal dose; two tablets; administered 1-2 hours post standardized meal depending on day or night dosing.

DRUG

Immediate release calcium carbonate tablet (BAY1180654)

Singal dose; two tablets; administered 1-2 hours post standardized meal depending on day or night dosing.

Trial Locations (1)

G4 0SF

BDD Pharma Bio-imaging Unit, Glasgow

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT06293326 - A First-in-Human Study to Learn How Well a Bi-Layer Calcium Carbonate Antacid Tablet Works Compared to a Standard, Non-Layered Calcium Carbonate Tablet in Healthy Male Participants | Biotech Hunter | Biotech Hunter